Navigation Links
MMJ International Holdings Enters Cannabis Study Agreement with BioInformatics and Genomics Center (BIG) at the University of Buffalo, New York
Date:6/5/2017

The Buffalo Institute for Genomics and Data Analytics (BIG) — a University of Buffalo program —has announced a strategic partnership with MMJ International Holdings. (MMJIH.com)

The University of Buffalo Bio Informatics and Genomics Center (BIG), part of the Governor Andrew M. Cuomo’s Buffalo Billion investment to grow jobs through the innovation economy, will invest $800,000 in support of MMJ International Holding’s medical cannabis research project in Buffalo.

MMJ International Holdings is the holding company managing multiple subsidiaries focused on advancing the science of medical marijuana through patient clinical research and the operation of medical cannabis healthcare businesses. The company is committed to taking a scientific approach to prove the efficacy of marijuana as a legitimate and effective medicine.

“MMJ International Holdings is working to attract the talent necessary for its medical cannabis research businesses to continue to bolster the economic growth in upstate and Western New York”, Tom Ryan COO said. “MMJIH’s move to Buffalo will create jobs, generate economic opportunity, and strengthen the region’s role as a leader in the future of the development of cannabis medicine. This partnership is a great economic stimulant for Buffalo and MMJ International Holdings. This team will place Western New York in the forefront of medical cannabis research internationally.”

The economic development partnership of the University of Buffalo and MMJIH will enable MMJIH to be the leader in medical cannabis clinical trials. Circuit Clinical, another University of Buffalo company, will assist MMJ International Holdings to bring new patients and physicians into medical marijuana clinical trials. A MMJIH proprietary telemedicine technology will significantly enhance outreach to doctors and their patients. The partnership could enable MMJ International Holdings to create over 100 jobs in the next five years. The University of Buffalo "BIG" investments will be made in increments as MMJ achieves annual job, investment, and product development milestones. In addition, part of its engagement with the University of Buffalo Bio Informatics and Genomics Center, MMJ International Holdings will expand its technology platform and bring software development jobs to Buffalo.

Chairman Timothy Moynahan commented, “By combining the University’s assets with those of MMJ, a positive economic impact can be achieved, while simultaneously enhancing medical cannabis clinical trial opportunities for Buffalo. The Clinical and Translational Science Award (CTSA) granted to the University of Buffalo, will pilot MMJ’s novel software methods which accompanied by rigorous scientific research will result in a data driven product formulation. While the partnership is a business enterprise there is no doubt it has altruistic dimensions; to provide safe and efficacious cannabis medicines, that alleviate pain, replace opioids, and diminish or eliminate disease.”

“Partnering with UB BIG helps us transform the patient experience in clinical research,” said MMJIH CEO, D Boise. “By enhancing our capabilities to develop technology, facilitate genomic research, and further the healthcare delivery system of medical cannabis through our relationship with UB, we’ll increase patient’s participation in a way that hasn’t been done before. We’ll bring patients the latest research advances in the safety and treatment of medical marijuana products. Our goal is to develop scientifically validated cannabis medicines and to facilitate their transition from the laboratory to the market place at lower costs.”

Read the full story at http://www.prweb.com/releases/2017/06/prweb14389923.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. SPIE Supports International Day of Light to Promote Awareness of Life-saving, Live-enhancing light
2. Delpor Selected by the NIH to Exhibit its Technology at the 2017 BIO International Convention
3. Cryos International – USA Proactively Prevents the Spread of Zika in Sperm Donations
4. Nerium International announces expansion into New Zealand
5. Nerium International Approved as Member of the Mexican Direct Selling Association A.C.
6. Leading International Spine Surgeons Praise AxioMed Viscoelastic Disc as "Game Changer" for Spine Surgery
7. SRI International Awarded Two BARDA Contracts to Provide Nonclinical Research Services
8. Kindred Biosciences Announces Global Sponsorship of International Society of Equine Locomotor Pathology
9. Astute Medical, Inc. Previews Scientific Presentations At Upcoming International Nephrology Conference
10. Nerium International Announces Official Membership in Canadian Direct Sellers Association
11. PuraCath Medical Shows Significant Reduction in Causes of Peritonitis in Peritoneal Dialysis International Journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/7/2019)... ... May 06, 2019 , ... "The ... growing number of repositories being asked to store cellular products being used ... of contributors who are world leaders, who have shared their expertise in building ...
(Date:5/4/2019)... ... May 03, 2019 , ... Diopsys Inc, ... Diopsys® ffERG/Photopic Negative Response vision test, a new full field electroretinography (ffERG) ... estimated that 6.3 million Americans will have glaucoma, with black Americans having the ...
(Date:5/2/2019)... ... , ... The centuries old practice of brewing beer thrives today across a ... even home brewing clubs scattered across the nation. , But proper beer brewing, ... produce a superb product. Students at South Dakota School of Mines & Technology ...
(Date:5/2/2019)... ... May 02, 2019 , ... ... will present results documenting discrepancies between U.S. insurer policies for genetic testing and ... risk for hereditary breast and ovarian cancer (HBOC). , Jill S. ...
Breaking Biology Technology:
(Date:5/14/2019)... ... 2019 , ... IMMUNE 3D®, a privately held biotechnology company, ... autoimmunity, fibrosis and skin immunology. In addition, the company will leverage its proprietary, ... , IMMUNE 3D®’s proprietary platform aims to study factors that affect immune ...
(Date:5/9/2019)... ... May 09, 2019 , ... Akadeum Life Sciences today ... on its microbubble technology. Unlike magnetic-based products, microbubbles use buoyancy to gently separate ... customers who participated in an early access program has been very encouraging and ...
(Date:5/8/2019)... ... 08, 2019 , ... MMS Holdings – an award-winning, data-focused ... Medrio , the leading provider of eClinical technology for small to mid-sized ... to position high-quality CRO services with Medrio’s fast and easy-to-use eClinical products, MMS ...
Breaking Biology News(10 mins):